That is because Alvotech and commercial partner Teva have claimed approval for their Simlandi biosimilar of Humira (adalimumab), which includes the first and so far only fully interchangeable ...

The MHRA has now updated guidance on the licensing of biosimilar products for interchangeability: “Once authorised, a biosimilar product is considered to be interchangeable with their reference ...